Gregory Fiore
Founder chez Exacis Biotherapeutics, Inc.
Fortune : - $ au 31/03/2024
Profil
Gregory Fiore was the founder of SSI Strategy LLC, founded in 2010, where he held the title of Chief Medical Officer.
He is also the founder of Sollis Therapeutics, Inc., founded in 2017, where he held the title of Chief Medical Officer & Vice President from 2019 to 2020.
Additionally, he is the founder of Exacis Biotherapeutics, Inc., founded in 2020, where he currently holds the title of President, Chief Executive Officer & Director.
Dr. Fiore is also the founder of Fiore Healthcare Advisors, Inc. He previously worked as the Chief Medical Officer at The Medicines Co. and as a Director at Eterna Therapeutics, Inc. in 2022-2023.
Dr. Fiore earned a doctorate degree from New York Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 26/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Gregory Fiore
| Sociétés | Poste | Début |
|---|---|---|
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The private company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Founder | 01/06/2020 |
Anciens postes connus de Gregory Fiore
| Sociétés | Poste | Fin |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Board Member | 03/10/2023 |
Sollis Therapeutics, Inc.
 Sollis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH. | Chief Executive Officer | 01/01/2020 |
Fiore Healthcare Advisors, Inc.
 Fiore Healthcare Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SSI Strategy LLC, Fiore Healthcare Advisors, Inc. provides pharmacovigilance and clinical research consulting services. The private company is based in Boston, MA. The company was founded by Gregory Fiore. Fiore Healthcare Advisors was acquired by SSI Strategy LLC on June 29, 2021. | Founder | - |
SSI Strategy LLC
 SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Founder | - |
| THE MEDICINES COMPANY | Chief Tech/Sci/R&D Officer | - |
Formation de Gregory Fiore
| New York Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
SSI Strategy LLC
SSI Strategy LLC Miscellaneous Commercial ServicesCommercial Services SSI Strategy owns and operates boutique management consulting firm. Its services include global medical affairs transformation, competency model development, post-merger integration, launch preparation, emerging markets medical affairs: organizational transformation, pharmacovigilance system enhancement and medical planning and tactic prioritization. The company was founded by Gregory Fiore in 2010 and is headquartered in Parsippany, NJ. | Commercial Services |
Sollis Therapeutics, Inc.
Sollis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sollis Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company developing novel non-steroid and non-opioid analgesics. The company was founded by Gregory Fiore and Bryan Jones and is headquartered in Columbus, OH. | Health Technology |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The private company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Health Services |
Fiore Healthcare Advisors, Inc.
Fiore Healthcare Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services Part of SSI Strategy LLC, Fiore Healthcare Advisors, Inc. provides pharmacovigilance and clinical research consulting services. The private company is based in Boston, MA. The company was founded by Gregory Fiore. Fiore Healthcare Advisors was acquired by SSI Strategy LLC on June 29, 2021. | Commercial Services |
